Silverarc Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Silverarc Capital Management's VCYT Position: Q1 2026 in Review
Silverarc Capital Management reduced its Veracyte (VCYT) stake by 50% in Q1 2026, selling an estimated $6.58M and leaving 179,700 shares worth $5.79M. The position accounts for 0.59% of the portfolio, ranked #40.
Silverarc Capital Management first reported a position in VCYT in Q1 2021 and has held it in 21 quarters since. The position peaked at $19.9M in Q4 2024. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Silverarc Capital Management held 179,700 shares of Veracyte worth $5.79M as of Q1 2026.
- Silverarc Capital Management sold 177,858 Veracyte shares in Q1 2026, an estimated $6.58M.
- Veracyte made up 0.59% of Silverarc Capital Management's portfolio in Q1 2026, its #40 holding.
- Silverarc Capital Management first reported a position in Veracyte in Q1 2021 and has held it in 21 quarters since.
- Silverarc Capital Management's Veracyte position peaked at $19.9M in Q4 2024.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Silverarc Capital Management's 13F filing for Q1 2026, filed 14 May 2026.